Lexie B2 Plus vs Otofonix Encore

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5, placing it in the top 9% of OTC devices tested in our lab. At $899, this behind-the-ear style device delivers strong performance in several key areas while showing some limitations worth considering. In our testing, the Lexie B2 Plus excels in speech clarity for quiet environments, scoring a strong 4.3/5—significantly above the OTC category average by 1.49 points. Own-voice comfort is a particular standout at 4.8/5, well above the category average by 2.29 points, meaning wearers are unlikely to experience the hollow or booming quality of their own voice that can make some hearing aids uncomfortable. Speech in noise performance scores 2.1/5, which is above the OTC category average by 0.58 points but remains mixed in absolute terms—typical for this device class. Music streaming scores 2.6/5, similarly above average by 0.68 points while remaining modest overall. Feedback handling at 2.8/5 falls below the category average by 1.74 points, which may require attention during phone calls or when wearing hats. The Lexie B2 Plus is a solid choice for users prioritizing speech clarity in quieter settings and natural own-voice comfort. It features rechargeable batteries and streaming compatibility with both iPhone and Android devices. This two-time Expert's Choice Award winner (2023, 2024) competes against devices like the higher-scoring Sony CRE-E10 in its price range, but offers a compelling balance of comfort and core speech performance.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.